On the basis of a patent that is short to be issued, three related pharmaceutical corporations requested a preliminary injunction, a final injunction, and a statement of responsibility per se against two generic businesses. The Examining Division of the European Patent Office had denied the claimants’ application, which they had anticipated being approved. The subject […]